Its mechanism of action potentially involves targeted inhibition of the PI3K/AKT/mTOR signaling pathway, thereby regulating G2/M phase arrest, apoptosis, and autophagy in NSCLC cells. This evidence concerns the gene MTOR and non-small cell lung carcinoma.